Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-APOC3 Transcript
Good afternoon, and welcome to Part 1 of the 2-part KOL Webinar series hosted by Arrowhead Pharmaceuticals. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Arrowhead website following the event. I would now like to turn the call over to your host, Vince Anzalone, Vice President of Investor Relations at Arrowhead Pharmaceuticals. Please go ahead, sir.
Thank you, Sara. Next slide, please. So I'm just going to give a quick welcome and introduction. We've got a lot to cover, so we will be quick to get to the content.
Next slide, please. So just reminding everybody that we will be making forward-looking statements today. So please refer to our regulatory filings for the risks to be considered in that regard.
Next slide. So we've got a very good panel today. We're fortunate to have Dr. Christie Ballantyne, who is from the Baylor College of Medicine. He's the Chief of Cardiology and the Chief of Cardiovascular
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
